| Inositol 1,4,5-trisphosphate synthesis in mononuclear white blood cells of malignant hyperthermia-susceptible and normal human beings, following in vitro exposure to halothane, caffeine and ryanodine. | |
| | |
MedLine Citation:
|
PMID: 10928436 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Despite a plethora of findings associated with the pathophysiology of malignant hyperthermia (MH), the in vitro contracture test (IVCT) is the only reliable test for diagnosis of this heterogeneous syndrome in man. An increase of 1,4,5-IP3 (inositol 1,4,5-trisphosphate), a second messenger involved in cellular calcium homeostasis, has been observed in muscle tissue of MH susceptible (MHS) patients. The aim of this study was to evaluate if the known differences of 1,4,5-IP3 content in muscle tissue might be reproduced in mononucleated white blood cells (MWBCs). Subsequently, MWBCs of 23 healthy controls and 12 patients with a clinical suspicion for MH disposition were isolated and screened for 1,4,5-IP3 content. An IVCT according to the protocol of the European Malignant Hyperpyrexia Group (EMHG) was performed on muscle specimens of 12 patients. Eight MHN and four MHS individuals were diagnosed. Additionally, 1,4,5-IP3 synthesis in MWBCs was detected following in vitro exposure to IVCT test substances halothane (2%), caffeine (1-30mM), and ryanodine (1-5 microM). A broad inter-individual variability of 1,4,5-IP3 content was observed in MWBCs of all volunteers, but no differences were detected between MHS and MHN individuals. These findings are in strong contrast to those observed in muscle tissue. In vitro exposure of isolated MWBCs to halothane, caffeine and ryanodine yielded no statistically significant differences between groups. A time- and concentration-dependent increase in cellular 1,4,5-IP3 content could be induced in some but not all individuals of both groups. Since no correlation was obtained between induction of 1,4,5-IP3-synthesis following in vitro exposure of MWBCs to MH test substances and MH disposition, this study was terminated. We conclude from our data that the detection of 1,4,5-IP3 synthesis in MWBCs is not suitable for diagnosis of MH disposition. It remains questionable whether an altered 1,4,5-IP3 metabolism in MWBCs is involved in pathologic cascades of MH. Therefore, other cell tissues should be evaluated in further studies to clarify the role of the 1,4,5-IP3 metabolism in MH. |
| | |
Authors:
|
U Martens; T Krause; J Scholz; F Wappler; K Steinrücke; J S am Esch |
Related Documents
:
|
16364156 - Pholcodine stimulates a dramatic increase of ige in ige-sensitized individuals. a pilot... 12931846 - Biomarkers in czech workers exposed to 1,3-butadiene: a transitional epidemiologic study. 8432676 - Effects of occupational exposure to mercury and lead on brainstem auditory evoked poten... 15804936 - Effects of subchronic exposures to concentrated ambient particles (caps) in mice. ii. t... 15617036 - The effect of glutamine supplementation on the function of neutrophils from exercised r... 6792956 - Inhibition of sulfur dioxide-induced bronchoconstriction by disodium cromoglycate in as... |
Publication Detail:
|
Type: In Vitro; Journal Article |
Journal Detail:
|
Title: European journal of anaesthesiology Volume: 17 ISSN: 0265-0215 ISO Abbreviation: Eur J Anaesthesiol Publication Date: 2000 Jun |
Date Detail:
|
Created Date: 2000-11-30 Completed Date: 2000-11-30 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8411711 Medline TA: Eur J Anaesthesiol Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 364-72 Citation Subset: IM |
Affiliation:
|
Department of Anaesthesiology, University Hospital Eppendorf, Hamburg, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anesthetics, Inhalation
/
pharmacology* Caffeine / pharmacology* Cell Separation Halothane / pharmacology* Humans Inositol 1,4,5-Trisphosphate / biosynthesis* Male Malignant Hyperthermia / metabolism* Muscle Contraction / drug effects Neutrophils / metabolism* Phosphodiesterase Inhibitors / pharmacology* Respiratory Muscles / drug effects Ryanodine / pharmacology* |
| Chemical | |
Reg. No./Substance:
|
0/Anesthetics, Inhalation; 0/Phosphodiesterase Inhibitors; 151-67-7/Halothane; 15662-33-6/Ryanodine; 58-08-2/Caffeine; 85166-31-0/Inositol 1,4,5-Trisphosphate |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Evaluation of the PhysioFlex closed-circuit anaesthesia machine.
Next Document: Evaluation of the effects of levobupivacaine on clotting and fibrinolysis using thromboelastography.